Illidge TM - Search Results

1

The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma.

Illidge TM, Cragg MS, McBride HM, French RR, Glennie MJ. Illidge TM, et al. Blood. 1999 Jul 1;94(1):233-43. Blood. 1999. PMID: 10381518 Free article.

2

Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.

Du Y, Honeychurch J, Glennie M, Johnson P, Illidge T. Du Y, et al. Cancer Res. 2007 Feb 1;67(3):1335-43. doi: 10.1158/0008-5472.CAN-06-2495. Cancer Res. 2007. PMID: 17283171

3

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy.

Du Y, Honeychurch J, Cragg MS, Bayne M, Glennie MJ, Johnson PW, Illidge TM. Du Y, et al. Among authors: illidge tm. Blood. 2004 Feb 15;103(4):1485-94. doi: 10.1182/blood-2003-06-2037. Epub 2003 Oct 23. Blood. 2004. PMID: 14576070 Free article.

4

Phase 1/2 study of fractionated (131)I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy.

Illidge TM, Bayne M, Brown NS, Chilton S, Cragg MS, Glennie MJ, Du Y, Lewington V, Smart J, Thom J, Zivanovic M, Johnson PW. Illidge TM, et al. Blood. 2009 Feb 12;113(7):1412-21. doi: 10.1182/blood-2008-08-175653. Epub 2008 Dec 12. Blood. 2009. PMID: 19074729 Free article. Clinical Trial.

5

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma.

Honeychurch J, Glennie MJ, Johnson PW, Illidge TM. Honeychurch J, et al. Among authors: illidge tm. Blood. 2003 Aug 15;102(4):1449-57. doi: 10.1182/blood-2002-12-3717. Epub 2003 Apr 24. Blood. 2003. PMID: 12714523 Free article.

6

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells.

Cragg MS, Bayne MB, Tutt AL, French RR, Beers S, Glennie MJ, Illidge TM. Cragg MS, et al. Among authors: illidge tm. Blood. 2004 Oct 15;104(8):2540-2. doi: 10.1182/blood-2004-05-1733. Epub 2004 Jun 22. Blood. 2004. PMID: 15213098 Free article.

7

Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.

Honeychurch J, Glennie MJ, Illidge TM. Honeychurch J, et al. Among authors: illidge tm. Cancer Res. 2005 Aug 15;65(16):7493-501. doi: 10.1158/0008-5472.CAN-04-3808. Cancer Res. 2005. PMID: 16103104

8

Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.

Illidge T, Honeychurch J, Vandersteen A, Cragg M. Illidge T, et al. Cancer Biother Radiopharm. 2000 Dec;15(6):581-91. doi: 10.1089/cbr.2000.15.581. Cancer Biother Radiopharm. 2000. PMID: 11190490

9

Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.

Tutt AL, French RR, Illidge TM, Honeychurch J, McBride HM, Penfold CA, Fearon DT, Parkhouse RM, Klaus GG, Glennie MJ. Tutt AL, et al. Among authors: illidge tm. J Immunol. 1998 Sep 15;161(6):3176-85. J Immunol. 1998. PMID: 9743386

10

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.

Alduaij W, Ivanov A, Honeychurch J, Cheadle EJ, Potluri S, Lim SH, Shimada K, Chan CH, Tutt A, Beers SA, Glennie MJ, Cragg MS, Illidge TM. Alduaij W, et al. Among authors: illidge tm. Blood. 2011 Apr 28;117(17):4519-29. doi: 10.1182/blood-2010-07-296913. Epub 2011 Mar 4. Blood. 2011. PMID: 21378274 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters